923283-85-6Relevant articles and documents
PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY
-
Page/Page column 34, (2016/09/26)
The present invention relates to pyrrolopyridazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY
-
Page/Page column 55, (2016/09/26)
The present invention relates to pyrazolopyrimidine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Pyrazolo pyrimidines useful as aurora kinase inhibitors
-
Page/Page column 100, (2010/11/25)
The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.